PROVIDER PROFILE · NPI 1952310500

Martha ArellanoMD

PRESCRIBING · PART D · 2024
Total Rx claims
296
Beneficiaries
Total drug cost
$2.5M
Distinct drugs
14
Brand share
60.5%
Top prescribed drugs
Ivosidenib37 claims
Dasatinib27 claims
Ponatinib Hcl19 claims
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
80.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
APM Entity